Clinical Trial Update: Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cryoablation in combination with metronomic cyclophosphamide for metastatic prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: RECRUITING